FTPP

Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide drug that has been studied for its potential in the treatment of obesity and certain types of cancer. In animal studies, Adipotide has shown promising results in reducing body weight and body fat in obese animals. It has been observed to induce weight loss, decrease body mass index (BMI), and improve metabolic parameters. While Adipotide has primarily been investigated for its potential as an anti-obesity agent, it has also shown some anticancer activity in preclinical studies.